Retinal Degeneration - Potsdam Meeting der ProRetina Stiftung 2017

A look at cutting-edge translational research

Friday, April 7, 2017

13:00-13:05 Welcome remarksFranz Badura, PRO RETINA FOUNDATION / RESEARCH DIVISION 13:05-14:30 Session 1 – Selected Poster Presentations8 abstracts to be selected 14:30-15:00 Keynote LectureMichael Brand, Dresden“Learning from the zebrafish: regeneration of the retina is possible – buthow does it work?“ 15:00-15:45 Coffee break 15:45-17:25 Session 2 – Modifying disease processes 15:45-16:10 Stephen H. Tsang, New York„Personalized therapeutic strategies for patients with retinitis pigmentosa“ 16:10-16:35 Sandro Banfi, Naples„The role of microRNAs in the human retina“ 16:35-17:00 Bernhard G. Herrmann, Berlin„Long non-coding RNA in development and disease“ 17:00-17:25 Francois Paquet-Durant, Tübingen„Targeting cGMP-signaling in inherited retinal degeneration“ 17:30 Dinner 19:00-20:00 Session 3 – Of men and mice in science 19:00-19:30 Eberhardt Zrenner, Tübingen„Hereditary retinal disorders: A pioneering field in biological research“ 19:30-20:00 Wolfgang Baehr, Salt Lake City„The rd mouse – a long story“ 20:00-open Swingin‘ Poster Session

Saturday, April 8, 2017

**09:00-10:40 Session 4 – „**An update on disease mechanisms“ 09:00-09:25 Peter Zipfel, Jena„12 years after: The search for complement inhibitors in AMD“ 09:25-09:50 Florian Sennlaub Paris„Complement Factor H controls macrophage life-span“ 09:50-10:15 Tim Krohne, Bonn„The NLRP3 inflammasome – new therapeutic target in macular degeneration“ 10:15-10:40 Najate AIT-ALI, Paris„Mode of action of RdCVF and its origin“ 10:40-11:15 Coffee break 11:15-12:55 Session 5 – „Innovative approaches to translation“ 11:15-11:40 Dr. Sebastian Bultmann, München„Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system. 11:40-12:05 Elly Tanaka, WienRegeneration of complex multi-tissue structures 12:05-12:30 Kathleen C. Keough, San Francisco„CRISPR/Cas9 Genome Surgery to Eliminate Dominant Negative Disease“ 12:30-12:55 Morgan Maeder, Cambridge Massachusetts„Envisioning a Gene Editing Approach to Treat Inherited Blindness“ 12:55-13:00 Concluding remarks 13:00 Lunch and end of meeting